Medical Care
Trans Physician Highlights Importance of Youth's Healthcare Autonomy
2024-12-04
A person holds up a sign reading ‘you are loved’. (Getty) Trans physician Navin Kariyawasam has provided a compelling explanation for why trans youth must have the autonomy to access gender-affirming healthcare in the face of legislative bans and restrictions. In the United States, 26 states have banned such care since 2022, and nearly 40% of the estimated 300,000 trans youth aged 13-17 live in these restrictive states. Anti-trans bills have a detrimental impact on the mental health of trans and non-binary youth, with one in six suffering from depression and anxiety related to transphobia.

Why Access to Healthcare is Life-Saving for Trans Youth

In her article published by the American Civil Liberties Union (ACLU), Navin Kariyawasam emphasized that access to healthcare and support is not only statistically beneficial but can be life-saving. She shared that in her work, having conversations with young people about their gender leads to fruitful discussions about their concerns and curiosities. Medical care, she explained, is about creating space for complex conversations that allow young people and their families to embark on a path of self-discovery together.

The Capacity for Gender Experimentation

The University of Toronto MD added that young people should have the right to make decisions about their bodies without political interference. From a young age, Navin Kariyawasam herself had the capacity to experiment with gender roles, which led her to have more complex thoughts about her gender identity. As she navigated this complex development, she lacked adults in her life to turn to for guidance and support. This is why, as a trans person and a physician, she understands the importance of young people and their families being able to communicate with trusted healthcare providers about the uncertainties they face.

Countering Conspiracy Theories

Navin Kariyawasam also addressed the conspiracy theory that gender-affirming care is used to force under-18s to identify as trans. She emphasized that no one makes the decision to seek gender-affirming care casually. Young people, their families, and their providers carefully consider this decision. She firmly stated that governments should not be allowed to make decisions about our bodies, and the proliferation of gender-affirming care bans is not only deeply transphobic but also sets a dangerous precedent.Trans youth deserve the autonomy to make decisions about their own healthcare. These bans and restrictions not only deny them the support they need but also have a negative impact on their mental health. We must recognize the importance of allowing trans youth to have a voice and the right to access the care they require. Let us work together to ensure that every trans youth feels loved and supported.
Healthcare Website Confirms Insight's Acquisition of PCRH
2024-12-04
Healthcare is a crucial sector that constantly undergoes significant changes and developments. One such event that has drawn attention is the official acquisition of PCRH by Insight. This acquisition holds great significance for the healthcare landscape and is likely to bring about various impacts and opportunities.

Unlock the Potential of Healthcare with Insight's Acquisition

Significance of the Acquisition

The acquisition of PCRH by Insight marks a significant milestone in the healthcare industry. It brings together two entities with unique strengths and capabilities, potentially leading to enhanced service offerings and improved patient care. Insight's expertise in healthcare management and PCRH's existing infrastructure and resources can combine to create a more comprehensive and efficient healthcare system.

From a business perspective, this acquisition allows Insight to expand its market reach and gain a foothold in a new region or patient population. It also provides an opportunity for synergies to be realized, such as cost savings through operational efficiencies and the sharing of best practices.

Impact on Patients

Patients are likely to be the primary beneficiaries of this acquisition. With the combined resources and expertise of Insight and PCRH, there may be improved access to healthcare services, increased quality of care, and the development of innovative treatment options. This could lead to better health outcomes for patients and a more positive healthcare experience.

Moreover, the acquisition may lead to increased investment in research and development, which can result in the discovery of new therapies and medical technologies. This, in turn, can have a profound impact on the future of healthcare and the well-being of patients.

Challenges and Opportunities

While the acquisition presents numerous opportunities, it also comes with its fair share of challenges. Integrating two different organizations with distinct cultures and operational processes can be a complex task. However, with proper planning and management, these challenges can be overcome, and the benefits of the acquisition can be maximized.

One of the key opportunities is the potential for growth and expansion. Insight can leverage PCRH's existing customer base and market presence to drive business growth and enter new markets. This can lead to increased revenue and profitability for the combined entity.

Future Outlook

The future outlook for the healthcare industry following this acquisition is promising. With the combined strengths of Insight and PCRH, there is potential for continued innovation and improvement in healthcare services. The acquisition may also set a precedent for other mergers and acquisitions in the industry, driving further consolidation and growth.

However, it will be important for both Insight and PCRH to remain focused on their core values and patient-centered approach. By doing so, they can ensure that the benefits of the acquisition are realized and that patients continue to receive the highest quality of care.

See More
Forbes Healthcare Summit: AI Boosts Healthcare Quality & Cuts Costs
2024-12-05
Dec. 4 (UPI) — At the 2024 Forbes Healthcare Summit in New York City, it was emphasized that artificial intelligence can significantly enhance the effectiveness and affordability of healthcare delivery. Ajay Shah, the co-founder and CEO of Cytovale, stated that AI tools are aiding patients in maintaining better health while caregivers are reducing their healthcare delivery costs. Cytovale is the producer of the IntelliSep AI tool specifically designed for diagnosing sepsis, a common, costly, and difficult-to-diagnose condition.When questioned about the healthcare benefits of AI tools like IntelliSep, Shah explained, "The conversation mainly revolves around the clinical operation and financial advantages for hospitals and healthcare systems." He further added, "Over the past year, we have been able to showcase a reduction in the length of stay by more than a day for each patient tested with IntelliSep. This is the result of enabling physicians and providers to make the correct diagnosis from the very first minute of a patient's visit, thereby dramatically altering their care pathways."Shah also highlighted the significance of addressing sepsis. "The long-term effects of sepsis are truly substantial. Promptly providing aggressive care to patients improves their long-term outcomes and reduces costs." The healthcare summit, an annual event sponsored by Forbes and attended by leaders in the $4 trillion healthcare industry, showcases the potential of AI.The National Institutes of Health reported in 2021 that AI is a powerful and disruptive area of computer science with the potential to fundamentally transform medical practice and healthcare delivery. It can assist healthcare systems worldwide in achieving the four-part goal of improving population health, patient care, caregiver experiences, and lowering healthcare delivery costs.The recent COVID-19 pandemic exposed the shortages in the available healthcare workforce and the inequities in accessing care. The NIH believes that AI could help alleviate these issues. "The application of technology and artificial intelligence in healthcare has the potential to address some of these supply-and-demand challenges," the NIH stated.President Joe Biden also recognizes the importance of AI. Last year, he issued an executive order requiring the federal government to "prioritize generative AI and other critical and emerging technologies" to accelerate their responsible use in healthcare systems and other industries.Biden emphasized, "AI holds extraordinary potential for both promise and peril. Responsible AI use can help solve urgent challenges and make our world more prosperous, productive, innovative, and secure. However, irresponsible use could exacerbate societal harms. Mitigating these risks requires a society-wide effort involving government, the private sector, academia, and civil society."The Healthcare Summit aligns with Biden's executive order. "The AI revolution is opening up new avenues for discovering drugs, personalizing medicine, and even managing a doctor's paperwork," the Healthcare Summit organizers stated. This invitation-only annual event at Murphy Alumni Hall, NYU Langone Health, is the 13th one held by Forbes.
See More